American Century Companies Inc Gritstone Bio, Inc. Transaction History

American Century Companies Inc

  • $167 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$1.96 - $2.9 $183,722 - $271,834
93,736 New
93,736 $240,000
Q2 2023

Aug 14, 2023
BUY
$1.66 - $3.03 $31,151 - $56,860
18,766 Added 97.34%
38,045 $74,000
Q1 2023

May 11, 2023
BUY
$2.13 - $3.74 $18,869 - $33,132
8,859 Added 85.02%
19,279 $53,000
Q4 2022

Feb 13, 2023
BUY
$2.17 - $3.92 $22,611 - $40,846
10,420 New
10,420 $35,000

Others Institutions Holding GRTS

# of Institutions
62
Shares Held
35.4M
Call Options Held
395K
Put Options Held
132K
View Full List

About Gritstone bio, Inc.

GRTS Quotes by TradingView
  • Ticker GRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 73,006,896
  • Market Cap $2.19M
  • Description
  • Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...
More about GRTS
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email